Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034063 (
pulmonary edema
)
10,665
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In 18 patients, myocardial injury was estimated by mathematical analysis of the rise in plasma activity of alpha-hydroxybutyrate (alpha-HBDH) dehydrogenase as observed by multiple sampling after admission. This enzyme represents the lactate dehydrogenase isoenzymes
LDH1
and LDH2. Changes in plasma volume were assessed by determining hematocrit values at the same time as the enzyme activities. Infarct size was expressed in IU/liter of plasma and in grams of heart muscle per liter of plasma (g/liter). Significant changes in plasma volume, reflected in hematocrit changes, occurred (average 12%): 10 patients without
pulmonary edema
showed an average change of 7%; for the group of eight patients with
pulmonary edema
, the change was 17%. When calculated infarct size was not correlated for plasma volume changes, a significant overestimation occurred (11.7%, range 0.7-29.7%). In the subgroup of patients with
pulmonary edema
the mean overestimation was 15.8%, and in patients without
pulmonary edema
, the mean overestimation was 8.5%. It is concluded that plasma volume changes after an acute myocardial infarction have to be taken into account when infarct size is calculated on the basis of plasma enzyme levels.
...
PMID:The influence of plasma volume changes on enzymatic estimation of infarct size. 103 93